Lawmakers are proposing a few tweaks to Minnesota's medical marijuana law.
Patients suffering from inflammatory bowel disease — now shut out of the program — could legally enroll with the Office of Medical Cannabis if the House and Senate agree. The program is already open to patients with Crohn's disease — one type of IBD — but not patients with related conditions such as ulcerative colitis.
It's a small change, but one that Dr. Kyle Kingsley, CEO of cannabis manufacturer Minnesota Medical Solutions, hopes will give more people access to a program that has struggled with low enrollment and high prices.
As of Friday, the state had enrolled 1,190 medical cannabis patients.
Read more
Minnesota Lawmakers Propose Medical Marijuana Program Changes
Recommended
